Dollars for Docs
How Industry Dollars Reach Your Doctors
Has Your Doctor Received Drug Company Money?
Pharmaceutical and medical device companies are now required by law to release details of their payments to a variety of doctors and U.S. teaching hospitals for promotional talks, research and consulting, among other categories. Use this tool to search for general payments (excluding research and ownership interests) made from August 2013 to December 2014. | Related Story: A Pharma Payment A Day Keeps Docs’ Finances OK »
in disclosed payments
doctors
companies
Top 50 Companies
Click on a company to see how its payments break down by drug, device or doctor. Or, see all companies »
Highest-Earning Doctors
| Name | Payments |
|---|---|
NARAYAN
SUJATA NARAYAN |
$43.9M |
UNDERWOOD
KAREN UNDERWOOD |
$28.5M |
BURKHART
STEPHEN BURKHART |
$24M |
YADAV
SANJAY YADAV |
$23.1M |
FOLEY
KEVIN FOLEY |
$22M |
Doctors Paid the Most Often
| Name | Payments |
|---|---|
ANA STANKOVIC |
1,711 |
FARHAD ZANGENEH |
1,610 |
JOHN FRITZ |
1,381 |
ROBERT BUSCH |
1,274 |
RUWANI GUNAWARDANE |
1,226 |
Payments in Your State
Click on a state to see payments made to doctors there.
About the Dollars for Docs Data
Details behind our drug company money database.
Source
The Centers for Medicare and Medicaid Services Open Payments data.
Archive
Search for payments made by 17 drug companies between 2009 and 2013.
Background Stories
Vying for Market Share, Companies Heavily Promote ‘Me Too’ Drugs
Our comprehensive analysis of drug company spending on doctors in the last five months of 2013 shows the most-promoted products typically were not cures, breakthroughs or top sellers.
Dollars for Dudes: Almost No Women Among Medical Industry’s Top-Paid Speakers, Consultants
The causes are not clear, but men account for more than 90 percent of the 300 doctors who received the most money from drug and medical device companies, according to new federal data.
Why Pharma Payments to Doctors Were So Hard to Parse
Flaws in information submitted to Open Payments, a government database of financial relationships in the medical field, complicated our analysis.
As Full Disclosure Nears, Doctors’ Pay for Drug Talks Plummets
Dollars for Docs Mints a Millionaire
What We’ve Learned from Four Years of Diving into Dollars for Docs
Docs on Pharma Payroll Have Blemished Records, Limited Credentials
Med Schools Flunk at Keeping Faculty Off Pharma Speaking Circuit
Big Pharma’s Big Fines
What Companies Disclose
Reporters, Use Our Data
Have questions about how you can best use Dollars for Docs for your own localized reporting? Contact us at communications@propublica.org.
Additional reporting, design & development by Al Shaw, Annie Waldman, Tobin Asher, Eric Sagara, Jeremy B. Merrill, Dan Nguyen, and Sisi Wei. Pharmacy, building, and first aid icons from The Noun Project.
Note: We have made some effort to normalize the data and eliminate duplicates, but data is primarily as it has been reported by the companies to the Centers for Medicare and Medicaid Services. If you spot an error, please let us know at drugs@propublica.org.
